Biden Administration Proposes Stricter Patient Privacy Rules for Abortion-Seekers
Mifepristone (Mifeprex), one of the two drugs used in a medication abortion, is displayed at the Women's Reproductive Clinic in Santa Teresa, N.M., on June 15, 2022. Robyn Beck/AFP via Getty Images
The Biden administration is taking new steps to protect the privacy of abortion-seekers after a federal judge halted the U.S. Food and Drug Administration’s (FDA) approval of the abortion drug mifepristone.
The new actions were announced on April 12, ahead of the third meeting of the interagency Task Force on Reproductive Health Access.
Samantha Flom
Author
Samantha Flom is a reporter for The Epoch Times covering U.S. politics and news. A graduate of Syracuse University, she has a background in journalism and nonprofit communications.
Contact her at [email protected].